Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-19 4:30 pm Purchase | 2026-02-12 | 13D | EVOMMUNE INC EVMN | LSP 7 Cooperatieve U.A. | 5,288,313 14.700% | 358,680 (+7.28%) | Filing History |
| 2026-02-17 07:00 am Purchase | 2026-02-09 | 13D | AGOMAB THERAPEUTICS NV AGMB | LSP 7 Cooperatieve U.A. | 5,141,992 10.600% | 5,141,992 (New Position) | Filing History |
| 2025-11-14 4:30 pm Purchase | 2025-11-07 | 13D | EVOMMUNE INC EVMN | LSP 7 Cooperatieve U.A. | 4,929,633 15.700% | 4,929,633 (New Position) | Filing History |
| 2025-02-12 4:30 pm Purchase | 2024-12-31 | 13G | OCULIS HLDG AG NAMEN AKT OCS | LSP 7 Cooperatieve U.A. | 5,752,894 13.800% | 425,532 (+7.99%) | Filing History |
| 2024-02-09 06:47 am Purchase | 2023-12-31 | 13G | OCULIS HLDG AG NAMEN AKT OCS | LSP 7 Cooperatieve U.A. | 5,327,362 14.600% | 5,327,362 (New Position) | Filing History |